Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Discover the key items to track in a monthly budget, from income to variable expenses, to ensure you meet your financial targets.
17,687 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Thursday brought a standout moment for investors tracking stock splits. A dedicated stock-split service captured atte...
Caterpillar has powered through a demanding cycle, but can its momentum persist into 2026? This guide digs into the d...
Investors are buzzing about a potential silver surge. This guide breaks down the chances of american silver going $70...
A major trading move shows Clearline Capital expanding its Core Scientific holding just as Bitcoin mining evolves int...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
Is Bloom Energy a buy, sell, or hold in 2026? This guide breaks down the business, potential catalysts, and key risks...
A bold bet on a geothermal energy company highlights a broader shift in the renewable energy stock year. Learn what i...
Nuclear energy is reclaiming attention as a reliable, low-emission power source. Here are three top picks that could ...
As Berkshire Hathaway enters a new chapter, investors wonder if berkshire's just break from Buffett's time-tested pla...
As data centers expand and AI workloads surge, a handful of tech leaders stand out as potential monster stocks hold n...